Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Great. Thank you so much. It's a pleasure to have Karyopharm up on stage with It's a pleasure to be back to in-person events. So I wanted to thank everyone for attending and enthusiasm and all your time at the conference. It's impressive to see things turn back 2 years since the last time we've done this conference and for many, it's the first in a couple of years that I want to thank everyone very much.
On that, my name is Peter Lawson. I'm one of the biotech analyst at Barclays. I'm the moderator for Karyopharm. I just want to thank, so we've got Richard Paulson, CEO from Karyopharm; Mike Mason, CFO; and we've also got Patricia Judson, Head of Medical Affairs (sic) [Strategy]
Strategy.
Strategy. Sorry I can't read my own writing.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
